Last Updated on December 31, 2023 by The Health Master
The US Food and Drug Administration (USFDA) granted approval for Merck’s (MSD outside the US and Canada) pneumococcal 15-valent conjugate vaccine, Vaxneuvance, for use in children aged six weeks to 17 years.
According to reports, the vaccine is intended for active immunization to prevent invasive diseases caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in people aged six weeks and above.
Moreover, it is the first pneumococcal conjugate vaccine to obtain approval in nearly ten years for invasive pneumococcal disease in paediatric populations.
Meanwhile, the recent approval for expanded indication to include use in children comes after the regulatory agency granted priority review for the supplemental application submitted by the company.
Reportedly, this was based on findings from seven double-blind, randomised, clinical trials that evaluated the safety, tolerability and immunogenicity of the vaccine in infants, children and adolescents.
“Our goal with Vaxneuvance is to expand coverage of key invasive disease-causing serotypes and provide a strong immune response to serotypes that pose a substantial risk to infants and children.”
“With this approval, we bring forward our first paediatric pneumococcal conjugate vaccine – and the first paediatric pneumococcal conjugate vaccine to be approved in almost a decade – building on our commitment to preventing invasive pneumococcal disease and on our legacy in paediatric vaccine development,” Merck Research Laboratories global clinical development senior vice-president, head and chief medical officer Dr Eliav Barr said in a statement.
USFDA approves this drug for the treatment for weight management
USFDA approves drug for Alopecia, includes safety warning too
USFDA gives tentative nod to Alembic Pharma for Dasatinib tablets
USFDA gives final approval for Adapalene and Benzoyl Peroxide Topical Gel
USFDA gives approval for Leuprolide Acetate Injection
USFDA gives final nod to Zydus for Famotidine tablets
Data security a priority for Pharma Companies in India
USFDA issues 6 observations to Glenmark Baddi Facility
New technology for safer Blood Transfusions at NCI Jhajjar
Haryana became the first state in the country to issue Drug Manufacturing Licenses online: HM
Govt notifies Surrogacy (Regulation) Rules for Surrogacy Clinics
UAFDA approves first Alopecia Drug that restores Hair Growth
Govt told to decide affordable price of Cancer Drug
Govt told to decide affordable price of Cancer Drug
Now TDS On Free Physician Samples
High Court to PCI: Open its portal for Pharmacy Colleges to submit application
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
